Altimmune, Inc. (ALT) Tops Q1 EPS by 6c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue